MFN

News

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.

News

Pharmacist shelving medicine in pharmacy

NHS could pay more for medicines under new plan

Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.

News

WAIT in neon lighting on black background

Pharma tariffs yet to emerge as Trump seeks more deals

Donald Trump looks set to delay the introduction of his tariffs on pharma imports in order to negotiate more deals with drugmakers on drug pricing.

News

Pfizer CEO Albert Bourla shakes hands with President Donald Trump in the White House.

Trump, Pfizer announce MFN deal; Lilly, others to come

At the White House today, President Trump and Pfizer CEO Albert Bourla announced the first of many deals to secure MFN drug prices for US consumers.

News

BMS says it will set Cobenfy's UK price the same as the US

Bristol Myers Squibb's price tag for schizophrenia drug Cobenfy in the UK is a manifestation of Trump's most favoured nation drug pricing policy.

Sales & Marketing

US drug pricing overhaul: The Inflation Reduction Act (IRA) ...

The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by granting Medicare the authority to negotiate prices for certain high-co

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

NHS could pay more for medicines under new plan

Pharma tariffs yet to emerge as Trump seeks more deals

Trump, Pfizer announce MFN deal; Lilly, others to come

BMS says it will set Cobenfy's UK price the same as the US

US drug pricing overhaul: The Inflation Reduction Act (IRA) ...

LSX2026: On a therapeutic vision for ocular disease, with Al...

Using AI-driven synthetic personas to take your insights fur...

MFN

Editor's Picks